Fmoc Solid-Phase Peptide Synthesis

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2024 Jul 12

PMID 38997478

Authors

Paul Robert Hansen

Alberto Oddo

Affiliations

Soon will be listed here.

Abstract

Synthetic peptides are important as drugs and in research. Currently, the method of choice for producing these compounds is solid-phase peptide synthesis. Here, we describe the scope and limitations of Fmoc solid-phase peptide synthesis. Furthermore, we provide a detailed protocol for Fmoc peptide synthesis.

Citing Articles

Peptide-Based Biomaterials for Combatting Infections and Improving Drug Delivery.

Lombardi L, Li J, Williams D Pharmaceutics. 2024; 16(11).

PMID: 39598591 PMC: 11597775. DOI: 10.3390/pharmaceutics16111468.

References

Sharma K, Sharma K, Sharma A, Jain R . Peptide-based drug discovery: Current status and recent advances. Drug Discov Today. 2022; 28(2):103464. DOI: 10.1016/j.drudis.2022.103464. View

Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G . Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022; 7(1):48. PMC: 8844085. DOI: 10.1038/s41392-022-00904-4. View

Vadevoo S, Gurung S, Lee H, Gunassekaran G, Lee S, Yoon J . Peptides as multifunctional players in cancer therapy. Exp Mol Med. 2023; 55(6):1099-1109. PMC: 10318096. DOI: 10.1038/s12276-023-01016-x. View

Li W, Separovic F, OBrien-Simpson N, Wade J . Chemically modified and conjugated antimicrobial peptides against superbugs. Chem Soc Rev. 2021; 50(8):4932-4973. DOI: 10.1039/d0cs01026j. View

Trier N, Hansen P, Houen G . Peptides, Antibodies, Peptide Antibodies and More. Int J Mol Sci. 2019; 20(24). PMC: 6941022. DOI: 10.3390/ijms20246289. View

Trier N, Hansen P, Houen G . Production and characterization of peptide antibodies. Methods. 2011; 56(2):136-44. DOI: 10.1016/j.ymeth.2011.12.001. View

Malonis R, Lai J, Vergnolle O . Peptide-Based Vaccines: Current Progress and Future Challenges. Chem Rev. 2019; 120(6):3210-3229. PMC: 7094793. DOI: 10.1021/acs.chemrev.9b00472. View

Behrendt R, White P, Offer J . Advances in Fmoc solid-phase peptide synthesis. J Pept Sci. 2016; 22(1):4-27. PMC: 4745034. DOI: 10.1002/psc.2836. View

Garcia-Martin F, Quintanar-Audelo M, Garcia-Ramos Y, Cruz L, Gravel C, Furic R . ChemMatrix, a poly(ethylene glycol)-based support for the solid-phase synthesis of complex peptides. J Comb Chem. 2006; 8(2):213-20. DOI: 10.1021/cc0600019. View

10.

Songster M, Barany G . Handles for solid-phase peptide synthesis. Methods Enzymol. 1997; 289:126-74. DOI: 10.1016/s0076-6879(97)89047-7. View

11.

Gongora-Benitez M, Tulla-Puche J, Albericio F . Handles for Fmoc solid-phase synthesis of protected peptides. ACS Comb Sci. 2013; 15(5):217-28. DOI: 10.1021/co300153c. View

12.

Barlos K, Chatzi O, Gatos D, Stavropoulos G . 2-Chlorotrityl chloride resin. Studies on anchoring of Fmoc-amino acids and peptide cleavage. Int J Pept Protein Res. 1991; 37(6):513-20. View

13.

Han Y, Bontems S, Hegyes P, Munson M, Minor C, Kates S . Preparation and Applications of Xanthenylamide (XAL) Handles for Solid-Phase Synthesis of C-Terminal Peptide Amides under Particularly Mild Conditions(1-3). J Org Chem. 1996; 61(18):6326-6339. DOI: 10.1021/jo960312d. View

14.

Chumachenko N, Novikov Y, Shoemaker R, Copley S . A dimethyl ketal-protected benzoin-based linker suitable for photolytic release of unprotected peptides. J Org Chem. 2011; 76(22):9409-16. DOI: 10.1021/jo2017263. View

15.

Subiros-Funosas R, Prohens R, Barbas R, El-Faham A, Albericio F . Oxyma: an efficient additive for peptide synthesis to replace the benzotriazole-based HOBt and HOAt with a lower risk of explosion. Chemistry. 2009; 15(37):9394-403. DOI: 10.1002/chem.200900614. View

16.

Jensen S, Thomsen T, Oddo A, Franzyk H, Lobner-Olesen A, Hansen P . Novel Cyclic Lipopeptide Antibiotics: Effects of Acyl Chain Length and Position. Int J Mol Sci. 2020; 21(16). PMC: 7461568. DOI: 10.3390/ijms21165829. View

17.

Erak M, Bellmann-Sickert K, Els-Heindl S, Beck-Sickinger A . Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics. Bioorg Med Chem. 2018; 26(10):2759-2765. DOI: 10.1016/j.bmc.2018.01.012. View

18.

Jahnsen R, Sandberg-Schaal A, Frimodt-Moller N, Nielsen H, Franzyk H . End group modification: Efficient tool for improving activity of antimicrobial peptide analogues towards Gram-positive bacteria. Eur J Pharm Biopharm. 2015; 95(Pt A):40-6. DOI: 10.1016/j.ejpb.2015.01.013. View

19.

Frederiksen N, Louka S, Mudaliar C, Domraceva I, Kreicberga A, Pugovics O . Peptide/β-Peptoid Hybrids with Ultrashort PEG-Like Moieties: Effects on Hydrophobicity, Antibacterial Activity and Hemolytic Properties. Int J Mol Sci. 2021; 22(13). PMC: 8268887. DOI: 10.3390/ijms22137041. View

20.

Zhu J, Pedersen M, Ahmed L, Abdolalizadeh B, Grell A, Berg J . Fluorescent Analogues of Human α-Calcitonin Gene-Related Peptide with Potent Vasodilator Activity. Int J Mol Sci. 2020; 21(4). PMC: 7072916. DOI: 10.3390/ijms21041343. View